Wound Care Market: Growth, Size, Share, and Trends

DRIVER: Increasing cases of traumatic injuries

The market for wound treatment is driven by the rising incidence of traumatic injuries, especially those resulting from industrial and road accidents. Around 1.3 million people are killed in traffic accidents each year, and another 20 to 50 million are injured in nonfatal ways, according to the World Health Organization. Most of these fatalities involve motorcyclists and pedestrians.

Moreover, around 270 million workplace accidents occur worldwide every year, according to the International Labor Organization. To avoid consequences like infection and tissue damage, these accidents frequently result in severe wounds that need proper wound care. Comprehensive and efficient wound treatment solutions are becoming more and more important in both conventional and emergency care settings as the number of trauma-related cases rises.

There are other countries too with high road traffic accident rates, such as India, China, and the US that are also witnessing a rise in demand for wound care products. As a result, healthcare systems are increasingly incorporating wound care products into standard treatment protocols, further driving market growth on a global scale for the wound care products market.

RESTRAINT: High cost of advanced wound care products

Despite their clinical effectiveness, advanced wound care products remain financially out of reach for many, particularly in low and middle-income countries with constrained healthcare budgets and limited insurance coverage. High-cost treatments such as bioengineered skin substitutes, antimicrobial dressings, and negative pressure wound therapy systems often impose a substantial economic burden on both patients and healthcare systems. According to research published in Advances in Wound Care, Chronic non-healing wounds, which affect an estimated 1 to 2% of the global population, can cost up to USD 50 million annually to manage. Among these, diabetic foot ulcers are especially common, impacting approximately 25 percent of individuals with diabetes and representing one of the leading causes of hospitalization. These cases significantly increase long-term healthcare spending. Further compounding the issue are recurring care needs such as frequent dressing changes, routine follow ups, and infrastructure requirements, including sterile environments and cold chain storage. These additional costs often restrict the use of advanced wound care solutions to only the most critical cases. In the absence of widespread reimbursement policies, price regulation, or government subsidies, access to these treatments remains limited, underlining the need for affordable and scalable alternatives to improve global availability.